Status:

UNKNOWN

Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia

Lead Sponsor:

Jiangsu HengRui Medicine Co., Ltd.

Collaborating Sponsors:

Beijing 302 Hospital

Beijing Anzhen Hospital

Conditions:

Non-hypovolemic Non-acute Hyponatremia

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

PHASE3

Brief Summary

This drug has been developed to treat Hyponatremia. The primary purpose of this study is to verify the efficacy and safety of seven-day repeated oral administration of tolvaptan at 15, 30, and 60 mg o...

Eligibility Criteria

Inclusion

  • Inclusion Criteria (for CHF):
  • Patients with CHF who exhibit edema, jugular venous distention, hepatomegaly, or pulmonary congestion.
  • Non-hypovolemic and Non-acute hyponatremia with a serum sodium \< 135mEq/L before randomization.
  • Patients who have taken furosemide at 40 mg/d or more (oral dosing) without alteration of dosage for the 3 days of the observation period.
  • Patients whose body weight has been stable (±1.0 kg) for 2 days prior to commencement of study drug administration.
  • Age:18~80 (when informed consent is obtained),male or female.
  • In-patient subjects.
  • Informed consent.
  • Inclusion Criteria (for hepatic cirrhosis):
  • Patients with hepatic edema.
  • Non-hypovolemic and non acute hyponatremia with a serum sodium \< 135mEq/L before randomization.
  • Age:18~65 (when informed consent is obtained),male or female.
  • In-patient subjects.
  • Informed consent.
  • Inclusion Criteria (for SIADH and others):
  • Patients with SIADH arising from a variety of etiologies.
  • Non-hypovolemic and non acute hyponatremia with a serum sodium \< 135mEq/L before randomization.
  • Age:18~80 (when informed consent is obtained),male or female.
  • In-patient subjects.
  • Informed consent.

Exclusion

    Key Trial Info

    Start Date :

    January 1 2012

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 1 2012

    Estimated Enrollment :

    240 Patients enrolled

    Trial Details

    Trial ID

    NCT01507727

    Start Date

    January 1 2012

    End Date

    September 1 2012

    Last Update

    January 11 2012

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    Cardiology, Beijing An Zhen Hospital Affiliated to Capital University of Medical Science

    Beijing, China

    2

    Endocrinology, Beijing Friendship Hospital

    Beijing, China

    3

    Hepatology, No. 302 Hospital

    Beijing, China